Development and Characterization of a ssDNA-based Aptamer that Selectively Targets Epithelial Carcinoma Cells

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Molecular Biomarkers & Diagnosis

• Publication date

  2014-11-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4172/2155-9929.1000204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Aptamers in Therapeutics.

  2016cited by this paper
• The International Journal of Biochemistry & Cell Biology

  2015cited by this paper
• A cell-based single-stranded DNA aptamer specifically targets gastric cancer.

  2014cited by this paper
• Current Progress of Aptamer-Based Molecular Imaging

  2014cited by this paper
• Selection of DNA aptamers against uropathogenic Escherichia coli NSM59 by quantitative PCR controlled Cell-SELEX.

  2014cited by this paper
• Aptamer-based therapeutics of the past, present and future: from the perspective of eye-related diseases.

  2014cited by this paper
• Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment.

  2014cited by this paper
• Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics

  2014cited by this paper
• Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamers.

  2014cited by this paper
• DNA Aptamer Technology for Personalized Medicine.

  2014cited by this paper
• Aptamers targeting rabies virus-infected cells inhibit street rabies virus in vivo.

  2014cited by this paper
• Tufting Enteropathy Revisited: The Utility of MOC31 (EpCAM) Immunohistochemistry in Diagnosis

  2014cited by this paper
• Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy

  2014cited by this paper
• Aptamer-based biosensors for biomedical diagnostics.

  2014cited by this paper
• The application of aptamers in cancer research: an up-to-date review.

  2013cited by this paper
• EpCAM: structure and function in health and disease.

  2013cited by this paper
• Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.

  2013cited by this paper
• Detecting Circulating Tumor Cells: Current Challenges and New Trends

  2013cited by this paper
• Generating Aptamers by Cell-SELEX for Applications in Molecular Medicine

  2012influential reference
• Aptamer-based molecular imaging

  2012cited by this paper
• Targeted Delivery of Chemotherapy Agents Using a Liver Cancer-Specific Aptamer

  2012cited by this paper
• Aptamers and the next generation of diagnostic reagents

  2012cited by this paper
• Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.

  2012cited by this paper
• Molecular imaging with nucleic acid aptamers.

  2011cited by this paper
• A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma

  2011cited by this paper
• Nucleic acid aptamers: clinical applications and promising new horizons.

  2011cited by this paper
• Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging

  2011cited by this paper
• Contribution of biomarkers and imaging in the management of hepatocellular carcinoma.

  2011cited by this paper
• Recent developments in protein and cell-targeted aptamer selection and applications.

  2011cited by this paper
• Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues

  2010cited by this paper
• EpCAM in carcinogenesis: the good, the bad or the ugly.

  2010cited by this paper
• Aptamers selected by cell-SELEX for application in cancer studies.

  2010cited by this paper
• Development of DNA aptamers using Cell-SELEX

  2010cited by this paper
• DNA Aptamers as Molecular Probes for Colorectal Cancer Study

  2010influential reference
• Combination of an aptamer probe to CD4 and antibodies for multicolored cell phenotyping.

  2010cited by this paper
• Aptamers against prion proteins and prions

  2009cited by this paper
• Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells

  2009cited by this paper
• Generating aptamers for recognition of virus-infected cells.

  2009cited by this paper
• EpCAM (CD326) finding its role in cancer

  2007cited by this paper
• Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.

  2007cited by this paper
• SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.

  2007influential reference
• Molecular imaging strategies for drug discovery and development.

  2006cited by this paper
• Epithelial Progenitors in the Normal Human Mammary Gland

  2005cited by this paper
• The biology of the 17–1A antigen (Ep-CAM)

  1999cited by this paper

• EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment

  2024influential citation
• EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging.

  2021cites this paper
• Recent progress in the development of aptasensors for cancer diagnosis: Focusing on aptamers against cancer biomarkers

  2021cites this paper
• Integrated bio-affinity nano-platform into a microfluidic immunosensor based on monoclonal bispecific trifunctional antibodies for the electrochemical determination of epithelial cancer biomarker.

  2017cites this paper
• Conjugates of small targeting molecules to non-viral vectors for the mediation of siRNA.

  2016cites this paper